XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
RSUs
Common Stock
Common Stock
RSUs
Additional Paid-In Capital
Additional Paid-In Capital
RSUs
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance, shares (in shares) at Apr. 30, 2023     113,943          
Beginning Balance, Amount at Apr. 30, 2023 $ 929,665   $ 113   $ 1,740,174   $ (385) $ (810,237)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Vesting of early exercised Class A common stock options (in shares)     2,084          
Vesting of early exercised Class A common stock options 9,571   $ 2   9,569      
Vesting of early exercised Class A common stock options 151       151      
Shares withheld related to net share settlement of equity awards (in shares)     (172)          
Shares withheld related to net share settlement of equity awards (7,118)       (7,118)      
Vesting of restricted stock units (in shares)       2,070        
Vesting of restricted stock units   $ 21,468   $ 2   $ 21,466    
Stock-based compensation expense 43,436       43,436      
Other comprehensive loss (373)           (373)  
Net loss (64,358)             (64,358)
Ending Balance, shares (in shares) at Jul. 31, 2023     117,925          
Ending Balance, Amount at Jul. 31, 2023 932,442   $ 117   1,807,678   (758) (874,595)
Beginning Balance, shares (in shares) at Apr. 30, 2024     123,706          
Beginning Balance, Amount at Apr. 30, 2024 $ 873,353   $ 123   1,963,726   (563) (1,089,933)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Vesting of early exercised Class A common stock options (in shares) 434   430          
Vesting of early exercised Class A common stock options $ 3,125   $ 1   3,124      
Vesting of early exercised Class A common stock options 105       105      
Shares withheld related to net share settlement of equity awards (in shares)     (107)          
Shares withheld related to net share settlement of equity awards (2,945)       (2,945)      
Vesting of restricted stock units (in shares)       2,176        
Vesting of restricted stock units   $ 22,280   $ 2   $ 22,278    
Stock-based compensation expense 40,986       40,986      
Other comprehensive loss 844           844  
Net loss (62,827)             (62,827)
Ending Balance, shares (in shares) at Jul. 31, 2024     126,205          
Ending Balance, Amount at Jul. 31, 2024 $ 874,921   $ 126   $ 2,027,274   $ 281 $ (1,152,760)